← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2012Last known activity
Mar 31, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT05569772CollaboratorPhase 3Mar 31, 2023
- NCT03747562CollaboratorPhase 3Mar 1, 2019
- NCT02910375CollaboratorPhase 4Dec 31, 2016
- NCT01596933Overall official - principal investigatorPhase 2/Phase 3Apr 1, 2012
- NCT01596933Lead sponsorPhase 2/Phase 3Apr 1, 2012
- NCT01596933Reponsible party - principal investigatorPhase 2/Phase 3Apr 1, 2012
Details
- Last known activity
- Mar 31, 2023